FDA Inspection
Fresenius Kabi iPSUM SrlFresenius Kabi iPSUM Srl – FDA Inspection, Feb 11, 2011
Record Details
This FDA Inspection record concerns Fresenius Kabi iPSUM Srl, with an inspection on February 11, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Fresenius Kabi iPSUM Srl
- Inspection Date
- February 11, 2011
- Product Type
- Drugs
View Company Profile
ID · 21e4d58d-a28a-47e3-a48e-9ac890078d0d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 712032
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Fresenius Kabi iPSUM Srl
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 21, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi iPSUM Srl
- FDA Inspection 1277643 - 2022-01-21
- FDA Inspection 1123992 - 2019-12-06
- FDA Inspection 1078083 - 2017-12-15
- FDA Inspection 993733 - 2016-11-17
- FDA Inspection 854585 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.